News

Euroseas Ltd. Prepares for Fourth Quarter 2024 Earnings Call

Euroseas Ltd. Prepares for Fourth Quarter 2024 Earnings Call

Upcoming Earnings Release for Euroseas Ltd.

ATHENS, Greece – Euroseas Ltd. (NASDAQ: ESEA), an industry leader in owning and operating container carrier vessels, is making waves in the shipping sector with their announcement surrounding the financial results for the fourth quarter that concluded on December 31, 2024. The company will unveil these results on February 27, 2025, prior to the market opening in New York.

Conference Call and Webcast Details

In conjunction with the earnings release, Euroseas' management is scheduled to host a conference call and webcast on the same day at 8:00 a.m. Eastern Time. This platform will allow investors and interested parties to engage with the latest developments and insights from the company.

Participate in the Conference Call

Participants wishing to join the call should connect 10 minutes before the start using the following numbers: 877 405 1226 for toll-free calls within the US, or +1 201 689 7823 for international dialing. It's important for attendees to mention “Euroseas” to the operator when connecting.

Alternative Registration Option

Additionally, Euroseas offers a convenient 'call me' option to streamline participation in the conference call. Users can submit their phone number, and the system will call them at the specified time.

Webcast Accessibility

The conference call will also feature a live audio webcast, followed by an archived session along with presentation slides. Interested listeners can find the information on Euroseas' website. To access the archived audio, attendees should navigate to the Investor Relations page of the website.

Presentation Availability

Minutes before the conference call, the slide presentation will be accessible in PDF format on the Euroseas website, allowing participants to download the necessary materials for further review.

About Euroseas Ltd.

Euroseas Ltd. was established on May 5, 2005, to consolidate the shipping interests of the Pittas family, who have been involved in maritime operations for over 150 years. The company trades on the NASDAQ Capital Market with ticker ESEA and specializes in container shipping operations. Euroseas is primarily guided by Eurobulk Ltd., an ISO-certified ship management entity that oversees the day-to-day operations of their fleet.

Fleet Composition

Following the strategic spin-off of three subsidiaries into Euroholdings Ltd., Euroseas boasts a fleet of 22 vessels, which includes 15 feeder containerships and 7 intermediate containerships. Collectively, these vessels have a cargo capacity of 67,494 twenty-foot equivalent units (teu). By 2027, the fleet is expected to expand to 24 vessels with a total capacity of 76,094 teu, further solidifying Euroseas' market presence.

Contact Information

For inquiries, stakeholders can reach out to Euroseas Ltd. via the following contacts:

Financial Media Relations

Tasos Aslidis, Chief Financial Officer
Euroseas Ltd.
Tel: (908) 301-9091
Email: aha@euroseas.gr

Investor Relations

Nicolas Bornozis, Capital Link, Inc.
Tel: (212) 661-7566
Email: euroseas@capitallink.com

Frequently Asked Questions

What is the date for Euroseas Ltd.'s quarterly results release?

Euroseas Ltd. will release its fourth quarter results on February 27, 2025.

How can I participate in the conference call?

To join the call, dial 877 405 1226 for toll-free access in the US or +1 201 689 7823 for international calls.

Will the conference call be accessible as a webcast?

Yes, there will be a live audio webcast of the conference call, with an archived version available after the event.

What is the current size of Euroseas' fleet?

Euroseas operates a fleet of 22 vessels, which will expand to 24 by 2027.

Who can I contact for media inquiries?

Tasos Aslidis is the Chief Financial Officer, and can be reached at (908) 301-9091 or via email at aha@euroseas.gr.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 8

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 371

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 283

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 334

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 442

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 247

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 278

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 460

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 522

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 438

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading

Top 5 Most Recently Viewed Articles

HCW Biologics Advances T-Cell Engagers for Solid Tumors

Updated Category News Views 181

HCW Biologics Unveils Innovative Treatments for Solid Tumors HCW Biologics Inc., a clinical-stage biopharmaceutical company, recently announced important developments in its research on second-generation, multi-specific T-cell engagers. These therapies specifically target solid tumors, notably pancreatic cancer, utilizing the company's proprietary TRBC product discovery...

Continue Reading
Highlights of the Upcoming Small Cap Growth Investor Event

Updated Category News Views 56

Overview of the Small Cap Growth Virtual Investor Conference The Small Cap Growth Virtual Investor Conference is set to take place soon, bringing together a diverse group of companies and investors. This exciting virtual event will provide a platform for companies to showcase their offerings to interested investors from various backgrounds. The conference promises an...

Continue Reading
Crexi Auction Performance Highlights Investor Reengagement

Updated Category News Views 286

Introduction to Crexi Auction's 2025 Performance As the landscape of commercial real estate evolves, Crexi Auction stands out with remarkable performance metrics indicating a strong rebound in market confidence. Recent reports highlight a 96% close rate for Crexi Auction during the first half of the year, showcasing a notable 10% year-over-year increase in transaction...

Continue Reading
Digihost and NANO Nuclear Jointly Propel New York's Energy Future

Updated Category News Views 145

Digihost and NANO Nuclear Join Forces for Renewable Energy Digihost Technology Inc. and NANO Nuclear Energy Inc. have united to submit a proposal to the New York State Energy Research and Development Authority (NYSERDA). Their aim? To facilitate the development of cutting-edge, clean energy solutions that will revolutionize New York's energy landscape. This collaboration...

Continue Reading
Syndax Pharmaceuticals (NASDAQ: SNDX) Faces Market Challenges

Updated Category News Views 151

Syndax Pharmaceuticals (NASDAQ: SNDX) and Its Market Journey Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) has recently made headlines as its stock price has fallen to a 52-week low of $12.75. This decline is indicative of the current hurdles the biopharmaceutical company is facing in a challenging market landscape. Investors have noted that the stock is currently in an...

Continue Reading